Sign in / Join Now
ETFs & Funds
Why I'm bullish on
Add a reply...
Latest StockTalks »
people get LGND breaking news and analysis by email alert.
Get email alerts on LGND »
Ligand Pharmaceuticals Incorporated
Get latest price
From other sites
Ligand Licenses Four Programs To Seelos Therapeutics
at TheStreet (Thu, 9:00AM)
Ligand Enters OmniAb® License Agreement With TeneoBio, Inc.
at TheStreet (Sep 16, 2016)
Commit To Purchase Ligand Pharmaceuticals At $100, Earn 10.8% Annualized Using Options
at Nasdaq.com (Sep 15, 2016)
Ligand Initiates Phase 2 Trial With LGD-6972 In Type 2 Diabetes
at TheStreet (Sep 13, 2016)
Ligand Partner Retrophin Announces Positive Top-Line Results From Phase 2 DUET Study Of Sparsentan In Patients With Focal Segmental Glomerulosclerosis
at TheStreet (Sep 7, 2016)